Increase in Prevalence of Breast Cancer, and Rise in Number of Breast Reconstruction Treatments to Drive Market Growth
Recent advances in surgical techniques and procedures allow plastic surgeons to recreate breasts that feel and look natural. Although no one elects to have a mastectomy, it can be reassuring to know there are options to help restore one’s appearance and put cancer behind. In some cases, mastectomy patients who undergo breast reconstruction surgery find that their reconstructed breasts may be firmer, more youthful, and more attractive than their natural breasts. This primarily fuels demand for reconstruction procedures, thereby pushing the growth of breast reconstruction market. Breast reconstruction surgery can help feel better about one’s appearance, restore individual self-confidence, make breasts look even in size and shape, help one feel more comfortable in clothing, including bathing suits and bras, and eliminate the need for uncomfortable prostheses. These and more advantages continue to drive expansion of breast reconstruction market worldwide.
The global breast reconstruction market is expected to be driven by an increase in the prevalence of breast cancer, a rise in the number of breast reconstruction treatments, and an increase in demand for acellular dermal matrix. According to the World Health Organization, 2.3 million women in the world were diagnosed with breast cancer in 2020, with 685,000 deaths reported. Breast cancer is the most common cancer among Indian women, with a rate of 25.8 per 100,000 women and a fatality rate of 12.7 per 100,000. In the United States, approximately one in every eight women (13%) develops invasive breast cancer over her lifetime.
Breast reconstruction market is expected to develop even faster as the number of breast reconstruction treatments rises. According to the NCBI, the rate of post-mastectomy breast reconstruction jumped from 19.4% to 53.4% in 2019. Furthermore, the number of breast reconstruction treatments climbed from 78,882 in 2000 to 137,808 in 2020, according to the American Society of Plastic Surgeons (ASPS), driving market expansion. The breast implant is supported by the acellular dermal matrix. It produces positive results, particularly in patients undergoing immediate reconstruction following mastectomy. The rise in the number of surgeons using the matrix for breast reconstruction and augmentation, as well as increased awareness of the benefits of acellular dermal matrices in breast reconstruction, abdominal wall reconstruction, nasal reconstruction, and eyelid reconstruction, have all contributed to an increase in demand for the matrix.
Moreover, the advancement of technology, and the increase in demand for various breast reconstruction surgical processes such as nipple-areola complex (NAC) reconstruction, mammoplasty, nipple prosthesis, mastopexy, radical mastectomy, free flap breast reconstruction, and implant-based reconstruction are also enhancing the overall progress of breast reconstruction market.
Rising Demand for Silicone and Saline Breast Implants Enhancing Breast Implants Segment
In terms of product, breast implants accounted for more than 42% share in global breast reconstruction market value recorded in 2021. This can be attributed to an increase in the number of breast cancer cases and breast reconstruction treatments, as well as an increase in demand for silicone and saline breast implants. Breast reconstruction and augmentation procedures involve silicone and saline implants. Due to the significant number of silicone breast implantation procedures conducted worldwide, silicone implants accounted for most of the market in 2021. Moreover, the acellular dermal matrix (ADM) segment is expected to rise rapidly during the forecast period, as ADM is broadly utilized in implant-based reconstruction procedures to treat abnormalities such as rippling and contracture.
Developments in Breast Reconstruction Technology to Fuel Growth of North America Breast Reconstruction Market
In 2021, North America accounted for a significant portion of the global breast reconstruction market. This trend is anticipated to continue during the forecasted period. Technological improvements in breast reconstruction devices, an increase in the number of businesses manufacturing breast implants and acellular dermal matrices, and a constant rise in the prevalence of breast cancer are all contributing to the market's growth in the region. For instance, according to ISAPS reports, the total number of breast reconstruction procedures conducted in the United States in 2019 was 541,167 and this increased to 596,896 in 2020. Sales of breast reconstruction products in Canada, the U.S., and Latin America are anticipated to be more due to high implant volume.
To meet the rising demand for breast implants in North America, market players are engaging in various strategic initiatives such as awareness campaigns, product launches, and geographic expansion. For instance, in October 2021, Sientra, Inc. and Mission Plasticos launched the philanthropic initiative 'Reshaping Lives: Full Circle' for American women living in poverty. The goal was to provide breast reconstruction after a mastectomy to low-income women. Additionally, the presence of well-developed healthcare infrastructure and rising healthcare spending in North America is likely to fuel the expansion of the breast reconstruction surgery and treatment market throughout the projected period.
Moreover, the Asia Pacific market is projected to be driven by a growth in the number of players releasing new products in countries such as China, India, Japan, and Australia, as well as an increase in the prevalence of breast cancer and high demand for breast implants. The increase in disposable income and the accessibility of surgical procedures in hospitals and ambulatory surgery centers are also expected to boost the Asia Pacific region's breast reconstruction market. Government programs to treat breast cancer are becoming more prevalent in India. For instance, in February 2018, the state health department of Tamil Nadu, India, opened a free cosmetic surgery facility at the Government Stanley Medical College and Hospital, which provides free breast reconstruction, breast augmentation, and breast reduction surgeries to those who are poor.
Global Breast Reconstruction Market: Competitive Landscape
Companies in the market are releasing new products alongside initiation collaborations, alliances, and partnership agreements. For instance, in 2022, Mentor Worldwide LLC (Johnson & Johnson) (US) received the new MENTOR Memory Gel boost breast implant, which has been authorized by the US Food and Drug Administration (FDA). On the other hand, in May 2021, the C Aesthetics launched PERLE in Europe, the next generation of breast implants, which is a revolutionary round breast implant with (R) evolutionary BioQ–surface technique and extremely cohesive Emunomic Breast Tissue Dynamic Gel.
Few of the players in the breast reconstruction market include Silimed (Brazil), Mentor Worldwide LLC (Johnson & Johnson) (US), Establishment Labs S.A. (US), Allergan Aesthetics (an Abbvie company) (US), RTI Surgical Holdings (US), Ideal Implant Incorporated (US), Integra Lifesciences (US), Sebbin (France), Sientra (US), GC Aesthetics (Ireland), and Polytech Health & Aesthetics (Germany).
Global Breast Reconstruction Market is Segmented as Below:
Key Elements Included In The Study: Global Breast Reconstruction Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Under uncertainty, traditional approaches to strategic planning can be downright dangerous. True ambiguity is no basis to forecast the future – degree of risk, the magnitude of circumstances, conditions and consequences are not known or unpredictable. To avoid dangerous binary views of uncertainty; strategic posture, moves and actions through market research is the best bet.Read more